More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Approval Granted for Large-Scale Research Project with IHPS

Aug 26, 2019 at 10:27 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Aug 26, 2019 at 10:27 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/approval-granted-for-large-scale-research-project-with-ihps

Argent Biopharma Ltd on 6ix

Story so far

  • Cultivation Licence Granted by the Office of Drug ControlMay 29, 2019
  • EU Medical Cannabis License Granted with Strategic AgreementJun 5, 2017
  • European CPNP Approval Granted for Derma ProductsJan 9, 2017

Earlier from Argent Biopharma

  • Trial on the Effect of CannEpil on Driver CompetencyAug 23, 2019
  • Canaccord to Lead LSE Listing and $4.75m Placement ClosedAug 21, 2019
  • MXC 100 Patient Milestone in Aus, Onboards Tetra HealthAug 12, 2019
  • MGC Signs Agreement for Construction of GMP Pharma FacilityAug 8, 2019
  • Additional Information on Ground-breaking ResearchJul 29, 2019

Later from Argent Biopharma

  • Appendix 4E and Audited 2019 Financial ReportAug 28, 2019
  • Placement Settlement Complete, Info on the Priority OfferAug 29, 2019
  • Epilepsy Clinical Study Comparing CannEpil to 100% CBDSep 2, 2019
  • 200 Prescription Milestone Passed in Australia & UKSep 17, 2019
  • MGC Pharma Passes 400 Prescription Milestone in SeptemberOct 2, 2019
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer